Dysregulated expression of the IL-2 receptor {beta}-chain abrogates development of NK cells and Thy-1+ dendritic epidermal cells in transgenic mice

The IL-2 receptor ß-chain (IL-2Rß), a specificity-determiningsubunlt In the IL-2R complex with a restricted tissue distributionpattern, Is essential for signal transductlon. Our previousstudies demonstrate that the continuous treatment of mice withanti-IL-2Rß) resulted in the complete disappearanceof NK cells and Thy-1⁺ dendritic epidermal cells (Thy-1⁺ dEC),suggesting that signals through IL-2Rß are criticallyinvolved in development of these lymphocyte subsets. However,these lymphocyte subsets are reported to be apparently unaffectedIn the IL-2-deficient mice. To further examine the biologicalroles of the IL-2Rß, transgenic mice carrying theIL-2Rß transgene were generated. In these mice, highlevels of the cell surface expression of the IL-2Rßwere observed in essentially all hematopoietic lineage cells,and CD4⁺ T cells as well as CD8⁺ T cells showed vigorous cellproliferation upon IL-2 stimulation. Surprisingly, NK cellsmarked with a high expression of NK1.1 in the spleen and Thy-1⁺dEC in the skin were completely absent in transgenic mice. However,the development of other lymphocyte subsets Including conventionalßTCR ⁺ cells, TCR⁺ cells and B cells remained apparentlyintact. From these observations together with previous dataon IL-2-deficlent mice, we speculate that factors, other thanIL-2 that utilizes the IL-2Rß as its functional receptorsubunlt, may have a vital role in the development of NK cellsand Thy-1⁺ dEC. Implications for possible In vivo functionsof over-expressed IL-2Rß are discussed.     

IL-7 induces proliferation of CD3 /low CD4 CD8 human thymocyte precursors by an IL-2 independent pathway

The proliferation potential of highly purified human CD3^–CD4^–CD8^–(triple negative) and CD3^low(lo)CD4^–CD8^– thymocyteprecursors in response to various cytokines was investigated.High in vitro growth ability was observed in response to recombinanthuman IL-2 (riL-2) and human riL-7, both in the absence of anyco-mitogen and in combination with phorbol 12-myristate 13-acetate(PMA). Furthermore, the proliferation of these thymocyte precursorsin the presence of rlL-7, although accompanied by a significantincrease of IL-2 receptor (IL-2R) p55 expression, appeared independentof that mediated by the autocrine IL-2 pathway, since mAbs toIL-2 and IL-2R p55 did not eliminate responsiveness to rlL-7.Synergism of rlL-7 with rlL-2 was also observed, while no cooperationwas detectable with rlL-4 or rlL-6. Analysis of surface phenotypeand cell cycle status of cells cultured in the presence of rlL-7,both plus and minus PMA, showed that CD3^– as well as CD3¹⁰cells readily proliferated to rlL-7. Upregulation of the levelsof expression of CD3 antigen was also observed in these cultures.These results, together with the previous characterization ofIL-7 as a human pre-B cell and mature T cell growth factor,Identify IL-7 as a cytokine with biologic activities on a varietyof target cells. They also suggest that IL-7, in analogy withthe mouse system, might play a role in human T cell ontogeny.     

Expression of the IL-2 receptor {gamma} chain on various populations in human peripheral blood

We have established two rat mAbs, TUGH4 and TUGh5, specificfor the human chain of the IL-2 receptor (IL-2R), which isknown to be shared among receptors for IL-2, IL-4 and IL-7.The antibodies bound to cell lines transfected with the human chain gene but not to their parental cell lines, and precipitated65–70 and 80–90 kDa cell surface molecules fromlysates of human T cells surface-labeled with Na¹²⁵I and chemicallycross-linked with ^[125]IL-2 respectively. Flow cytometry withTUGh4 and TUGh5 detected the chain in a wide variety of peripheralblood cell populations including CD4⁺ T cells, CD20⁺ T cells,CD20⁺ B cells, CD56⁺ natural killer cells, CD4⁺ monocytes andgranulocytes, contrasting with expression of the and ßchains of IL-2R.     

Transgenic mice expressing constitutive levels of IL-2 in islet {beta} cells develop diabetes

IL-2 plays an important role in the clonal expansion of T cellsduring an immune response and it has been implicated in autoimmunedisease. To examine the role of IL-2 in the regulation of peripheraltolerance we produced transgenic mice in which the expressionof murine IL-2 was directed by the rat insulin II promoter.The IL-2 transgene was expressed specifically in the pancreas.Islets from transgenic mice synthesized biologically activeIL-2. Expression of IL-2 in the pancreas resulted in a massiveinflammatory response directed at the ß cells of thepancreas. The infiltrate consisted primarily of B cells andCD4⁺ and CD8⁺ T cells. The infiltrate resulted in destructionof the insulin-producing ß cells and diabetes, butthere was no evidence for antigen specificity. The results suggestthat local IL-2 production elicits the recruitment and activationof cells capable of destroying ß cells by non-antigen-specificmechanisms.     

Activation-induced expression of thymic shared antigen-1 on T lymphocytes and its inhibitory role for TCR-mediated IL-2 production

We have produced a hamster mAb, PRST1, which reacts with thymicshared Ag-1 (TSA-1), a product of the Ly6 gene family. By cross-blockingexperiments, we found that TSA-1 is identical to stem cell Ag-2(Sca-2). Using PRST1, the changes of TSA-1/Sca-2 expressionon mature T cells during the activation process were analyzed.Although freshly isolated T cells did not express detectableTSA-1 on their cell surface, in vitro stimulation of T cellswith concanavalln A induced a marked increase of surface TSA-1expression. The increased expression of TSA-1 on T cells wasdetected from 12 h after stimulation and was associated withthe increase of TSA-1 mRNA. In vivo injection of mice with staphylococcalenterotoxin B (SEB) resulted in the enhanced TSA-1 expressionin splenic V_ß8⁺ T cells. This antigen-specific inductionof TSA-1 expression in vivo preceded a detectable increase innumbers of V_ß8⁺ T cells after SEB injection. Functionally,whereas anti-TSA-1 mAb was not mitogenic to T cells, it inhibitedanti-CD3-induced IL-2 production by T cell hybridomas. Theseresults indicate that TSA-1/Sca-2 is a unique marker for T cellactivation and a signal through this molecule may have a negativefeedback role to limit IL-2 production from activated T cellsstimulated through the TCR.     

Expression on cells of early human pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins.

Immunohistological studies of human first trimester pregnancy decidua demonstrated the presence of the p75 interleukin-2 receptor (IL-2R) and the p145 interleukin-4 receptor protein (IL-4R) on cells in the decidual stroma; there was no expression of CD25, the p55 IL-2R. The IL-4R was also expressed on the basal face of the glandular epithelial cells. Flow cytometric analysis of antibody-labelled decidual cell dispersions confirmed these results. Double antibody labelling demonstrated that p75 was expressed exclusively on the CD56-positive decidual large granular lymphocytes (LGL), whereas the IL4-R was expressed on some decidual LGL, and most decidual macrophages and T cells. In vitro incubation of decidual cells with IL-2 failed to induce expression of p55 or to increase the expression of either p75 or the p145 IL-4R. Purified decidual LGL proliferated in vitro in response to IL-2, and IL-4 inhibited this IL-2-induced proliferation.     

Differential effect of transforming growth factor-{beta}1 on the activation of human naive and memory CD4+ T lymphocytes

Transforming growth factor-ß1 (TGF-ß1) canhave stimulatory or inhibitory effects on cell growth. For severalcell types, the effect of TGF-ß1 was found to correlatewith the differentiation stage of the cells and the presenceof other cytoklnes. We have studied here the influence of TGF-ß1on CD4⁺ T cell activation in relation to the differentiationstage of the cells by evaluating the effect of TGF-ß1on the prollferatlve responses of purified CD4⁺CD45RA⁺ (unprfmed)and CD4⁺CD45RO⁺ (primed) lymphocytes. Under certain conditions,TGF-ß1 exerted a co-stlmulatory effect on peripheralblood CD4⁺CD45RA⁺ T cells whereas the outgrowth of CD4⁺CD45RO⁺T cells was suppressed in any activation system tested. Theenhancement of prollferatlve responses by TGF-ß1 inTCR/CD3 or CD2 stimulated cultures of CD45RA⁺ cells involvedup-regulatlon of CD25 expression and was dependent on the presenceof exogenous IL-2 or CD28 mAbs; IL-7 driven proliferatlve responseswere suppressed by TGF-ß1. These observations wereconfirmed in experiments with purified cord blood (CB) CD4⁺T cells inasmuch as addition of TGF-ß1 caused a 2-to 7-fold increase in IL-2 driven proliferatlve responses ofthese cells. Finally we show that, in contrast to the effectof TGF-ß1 during primary stimulation of CB CD4⁺ Tcells, TGF-ß1 suppressed T cell proliferation for40% in secondary cultures of these cell. Our findings indicatethat TGF-ß1 Is a blfunctlonal regulator of CD4⁺ Tcell growth in vitro, with co-stimulatory capacities duringCD45RA⁺ T cell mediated primary responses and growth suppresslveeffects during secondary responses of CD45RO⁺ T cells.     

IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells

Chimeric proteins containing antigen linked to cytokines haveshown some promise as vaccine candidates but little is knownof their mechanism of action, particularly at the level of theantigen-presenting cell. We have investigated this using a chimericprotein in which an immunodominant T cell epitope from influenzahemagglutinin peptide (HA), recognized in the context of I-E^d,was fused to IL-2. Immature murine dendritic cells (DC) derivedfrom bone marrow (BMDC) were used to present the chimeric proteinto a T cell hybridoma with TCR specific for the HA peptide (A5cell line). HA–IL-2 was found to induce significantlyhigher T cell activation than HA alone. Although the inclusionof IL-2 and HA separately did increase the response of A5 cellscompared to HA alone, they were not as effective as the HA–IL-2chimeric protein. When an antibody known to block IL-2 receptor chain (CD25) was included, A5 activation was reduced, suggestinga role for the receptor in this process. Expression of CD25on A5 cells was low during activation, implying that the effectwas mediated by CD25⁺ BMDC. Antigen uptake and processing ofHA–IL-2 by BMDC was required since fixing BMDC, priorto antigen exposure, greatly reduced their ability to activateA5 cells. The function of CD25 on DC is currently unknown. Ourresults suggest this receptor may play a role in antigen uptakeand subsequent T cell activation by receptor-mediated endocytosisof antigen attached to IL-2. This finding that may have implicationsfor the development of a new generation of vaccines.     

Regulation of IL-2 beta receptor expression and beta-chain mRNA by human thymocytes.

The high affinity form of the human IL-2 receptor (IL-2R) has two known components, the IL-2R alpha (p55) and the IL-2R beta chain (p75). We have previously shown that recombinant IL-2 (rIL-2) could induce the expression of the alpha-chain (p55) on T cells and thymocytes, and increase this expression following suboptimal activation with concanavalin A (Con A) in combination with IL-2. An increase in the accumulation of IL-2R alpha-specific mRNA induced by rIL-2 in T cells and thymocytes had also been documented. We report here that the expression of IL-2R beta on the cell surface can be demonstrated on human thymocytes by the binding of Mik beta1, a MoAb directed against an epitope of the beta-chain. The IL-2R beta chain is constitutively expressed on freshly isolated thymocytes; this expression can be increased in thymocytes activated with Con A in combination with IL-2 or tetradecanoylphorbol 13-acetate (TPA). Blocking the formation of high affinity receptors with a MoAb directed against the alpha-chain of the receptor results in an increase in the display of IL-2R beta as evidenced by binding of MoAb Mik beta1. The accumulation of IL-2R-beta-specific mRNA is observed in freshly isolated thymocytes and it is increased in thymocytes cultured with rIL-2 alone, with Con A, and further enhanced by the addition of rIL-2 in combination with Con A or with TPA. Cyclosporine (CsA), which inhibits the accumulation of lymphokine-specific mRNA of thymocytes, does not inhibit the induction of the accumulation of IL-2R beta-specific mRNA. This is analogous to its effect on the expression of the alpha-chain (p55), and the accumulation of alpha-chain-specific mRNA.     

Expression of IL-2 receptor p55 and p75 chains by human B lymphocytes: effects of activation and differentiation.

Whilst B cells in human blood can be shown to express interleukin-2 receptor (IL-2R) p55 and p75 chains, using a high-sensitivity immunofluorescence procedure, fresh tonsil B cells did not show detectable levels of expression. Culture of tonsil B cells led to low levels of expression of the p55 chain of the IL-2R, an effect which was dependent on protein synthesis. The level of expression of IL-2R chains could be modulated by culturing in the presence of a number of factors which activate B cells. p55 levels were more readily modulated than p75 levels. IL-4 and combinations of IL-4 with anti-IgM, IL-2 or tumour necrosis factor-beta (TNF-beta) modulated p55 levels, but IL-5 did not. Changes in IL-2R expression were small when compared with other B-cell activation markers such as CD23. When unfractionated tonsil cells were activated with a polyclonal stimulus, the major change was the expression of p55 by T-cell blasts--p75 expression remained low in T and B cells, and p55 expression by B cells remained low.     

IL-4 producing CD4+ TCR{alpha} {beta}int liver lymphocytes: influence of thymus, {beta}2-microglobulin and NK1.1 expression

The present report describes developmental, phenotypic and functionalfeatures of unconventional CD4⁺ TCRß lymphocytes.In C57BL/6 mice, the majority of liver lymphocytes expressingintermediate intensity of TCRß (TCRß^int)are CD4⁺NK1.1⁺ and express a highly restricted TCR V_ßrepertoire, dominated by V_ß8 with some contributionby V^ß7 and V^ß2. Although these cells expressthe CD4 co-receptor, they are present in H2-l Aß (Aß)^+/–gene disruption mutants but are markedly reduced in ß₂-microglobulin(ß₂m)^–/– mutant mice and hence are ß₂mdependent. Thymocytes expressing the CD4⁺NK1.1⁺ TCR ßphenotype are also (ß₂m) contingent, suggesting thatthese two T lymphocyte populations are related. The CD4⁺NK1.1⁺TCRßlymphocytes in liver and thymus share several markers such asLFA-1⁺, CD44⁺, CD5⁺, LECAM-1^– and IL-2Rßa. TheCD4⁺NK1.1 ⁺ TCRß^int liver lymphocytes were not detectedin athymic nuinu mice. We conclude that ß₂m expressionis crucial for development of the CD4⁺NK1.1⁺ TCRß^intliver lymphocytes and that thymus plays a major role. CD4⁺ TCRß^intliver lymphocytes were also identified in NK1.1⁺ mouse strains,there lacking the NK1.1 marker. We assume that the NK1.1 moleculeis a characteristic marker of the CD4⁺TCR"^int liver lymphocytesin NK1.1⁺ mouse strains, although its expression is not obligatoryfor their development. The liver lymphocytes from +₂m^+/–,but not from +₂m^–/–mice are potent IL-4 producersin response to CD3 or TCRß engagement and the IL-4production by liver lymphocytes was markedly reduced by treatmentwith anti-NK1.1 mAb. We conclude that the CD4+NK1.1⁺ TCRß^intliver lymphocytes are capable of producing IL-4 in responseto TCR stimulation.     

IL-13对成纤维细胞IL-13受体和IL-4受体表达的影响

目的研究IL-13对人肺成纤维细胞株HFL-1和人肝星状细胞株LX-2 IL-13受体和IL-4受体表达的调节作用。方法 RT-PCR法检测HFL-1细胞株和LX-2细胞株IL-13Rα1、IL-4R和IL-13Rα2 mRNA的表达;凝胶电泳定量软件Image Tool2.0对RT-PCR电泳条带进行光密度分析;ELISA法检测HFL-1细胞株和LX-2细胞株分泌可溶型IL-13Rα2以及检测细胞裂解液总IL-13Rα1、IL-4R和IL-13Rα2含量。结果 IL-13(5～100 ng/ml)对HFL-1细胞株和LX-2细胞株表达IL-13Rα1和IL-4R无影响;IL-13为5、10、20 ng/ml时能诱导HFL-1细胞株表达IL-13Rα2并呈现剂量依赖,当IL-13为50 ng/ml时,对HFL-1细胞株IL-13Rα2表达的诱导作用明显减弱,IL-13 100 ng/ml组没有检测到HFL-1细胞株IL-13Rα2的表达;LX-2细胞株IL-13Rα2表达缺失且IL-13不能诱导LX-2细胞株表达IL-13Rα2。结论 IL-13不能上调人肺成纤维细胞株HFL-1和人肝星状细胞株LX-2表达功能型受体IL-13Rα1和IL-4R,表明IL-13不能通过上调IL-13Rα1和IL-4R表达量来放大自身作用;一定浓度的IL-13能诱导人肺成纤维细胞株HFL-1表达抑制型受体IL-13Rα2,表明IL-13的自身负调控。     

Immunological characterization of antigenic domains on human IL 2 receptor {beta} subunit: epitope-function relationships

Five mAb directed at the IL-2R ß chain were analyzedfor their binding and functional properties. They define threeepitopes on a recombinant soluble ß chain or on theß chain expressed at the surface of YT-2C2 cells.Epitope 1 (A41 and 6E8 mAb) is part of the IL-2 binding domain,whereas epitope 2 (CF1 and 6E10 mAb) is not involved in IL-2binding. Epitope 3 (6B5 mAb) also partly overlaps the IL-2 bindingdomain but does not overlap epitopes 1 and 2. None of the mAbcan by themselves inhibit IL-2 induced proliferation of a humanactivated T cell clone. Only epitope 1 mAb can synerglze withan anti-ct chain mAb to inhibit this proliferation. Using epitope1 and 2 mAb as well as a purified, recombinant form of the IL-2Rp chain extracellular domain, an ELISA-based immunoassay wasset up which allows the quantitative determination of solubleand detergent solubillzed IL-2R ß chains. Epitopes1 and 2 are in non-competitive interaction: the binding of amAb to one epitope decreases the affinity of a mAb for the secondepitope. Epitope 2 mAb have binding stoichiometries ({smalltilde}16,000 sites/cell) which are {small tilde}80% higher thanthat of epitope 1 mAb and IL-2 itself ({small tilde}9000 sites/cell).Upon binding of epitope 2 mAb, the stoichiometries of epitope1 mAb and IL-2 are increased to reach the stoichiometry of epitope2 mAb. A molecular model is proposed in which the IL-2R ßchain exists in two different states on YT-2C2 cells: one associatedwith the intermediate-affinity IL-2R ;ß/ complex,the other being part of a receptor structure which is not accessibleto epitope 1 mAb and IL-2.     

NK1.1+ T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production

Particular subsets of T cells expressing the NK1.1 antigen havebeen proposed to play an immune regulatory role by their fastand strong production of cytokines, in particular IL-4. We soughtto determine factors driving the functional differentiationof NK1.1⁺ T cells. Since NK1.1⁺ T cells are exquisitely sensitiveto IL-7 stimulation, we analyzed the development, selectionand IL-4 production of NK1.1⁺ T cells in IL-7 deficient mice(IL-7–/–mice). Besides a sharp reduction of allT cell subsets, NK1.1⁺ T cells develop at normal relative frequenciesin IL-7–/–;mice. They also undergo a normal selectionprocess, as revealed by the biased V_ß TCR repertoireidentical to the one in IL-7+/+ mice. However, NK1.1₊ T cellsfrom IL-7+/+ mice were found to be impaired in IL-4 and IFN-production in in vitro and in vivo models. In addition, IL-7was able to restore IL-4 production by NK1.1⁺ thymocytes fromIL-7–/– mice. Finally, IL-7 but not IL-4 was ableto maintain and increase IL-4 production by NK1.1⁺ thymocytesfrom normal mice. These data suggest that the functional maturationof NK1.1⁺ T cells requires a cytokine-driven differentiationprocess, in which IL-7 plays a major role.     

Superantigen-reactive T cells that display an anergic phenotype in vitro appear functional in vivo

Clonal deletion and/or inactivation establishes tolerance toself antigens. Endogenous and exogenous (bacterial) superantigens,like the staphylococcal enterotoxlns, induce ligand-specificclonal anergy in vivo and thus are believed to mirror aspectsof post-thymic tolerance mechanisms in mature peripheral T cells.Here we analyzed the level of anergy of ligand-responsive V_ß8⁺T cells from staphylococcal enterotoxin B (SEB)-primed micein vivo and in vitro. Upon in vitro restimulation with SEB,CD4⁺V_ß8⁺ and CD8⁺V_ß8⁺ T cells failed toproduce IL-2. However, functional IL-2 receptors were triggered,since supplementation with IL-2 induced clonal growth in virtuallyall CD4⁺V_ß8⁺ and CD8⁺V_ß8⁺ T cells as determinedby limiting dilution analyses. Thus in vitro unresponslvenessof lymphocytes from SEB-primed mice reflects the inability ofSEB-reactlve V_ß8⁺ T cells to produce IL-2. Surprisingly,anergy as defined in vitro was at variance with that in vivo.Following further challenge with SEB, systemic and acute lymphokineproduction (Including IL-2 and tumor necrosis factor) occurredwith almost identical peak values and kinetics to primary invivo responses, and D-galactosamlne-sensltlzed mice succumbedto lethal shock. Polymerase chain reaction analyses revealedthat CD4⁺V_ß8⁺ expressed IL-2-specific mRNA in vivoupon restimulatlon with SEB. While lymphokine production andexpression of the IL-2 receptor was similar to the responseto in vivo primary stimulation, only CD8⁺V_ß8⁺ T cellsexpanded clonally upon reintroductlon of SEB in vivo. Henceprimed V_ß8⁺ T cells challenged with SEB display invitro anergy yet in vivo responsiveness, at least in part. Weconclude that the state of anergy is reversible, dependent uponthe quality of activation signals provided in in vivo ratherthan in in vitro culture conditions.     

Activation and 'deletion' of self-reactive mature and immature T cells during ontogeny of Mls-1a mice: implications for neonatal tolerance induction

We assessed the kinetics of V_ß6⁺ T cell eliminationin the lymph nodes and thymus during Mls-1^a mouse ontogeny.Our results suggest that induction of tolerance to Mls-1^a antigensinvolves mechanisms other than clonal deletion of immature Tcells in the thymus. Mature CD4⁺CD8^– (CD4SP) T cells wereaffected by Mls-1^a antigens earlier than immature thymocytepopulations. Up to 2 weeks after birth, reduced frequenciesof V_ß6⁺ T cells were detected only in CD4SP cellsfrom the thymus and lymph nodes, and generation of CD4SP cellsin the thymus was blocked at least 1 week earlier than thatof their CD4⁺CD8^loTCR^hl immature precursors. The number of V_ß6⁺CD4SPT cells increased during the first 2 weeks of life and remainedconstant thereafter. We thus found no evidence of deletion ofmature V_ß6⁺CD4SP T cells, as the reduced frequenciesin adult mice can be attributed to the dilution of previouslygenerated cells in lymphoid organs of growing mice, which increasein cellulartty after birth. V_ß6⁺CD4⁺ T cells wereactivated in vivo shortly after birth, as shown by a selectiveincrease in IL-2 receptor a chain expression in the thymus andlymph nodes from day 0 to day 2 after birth. It is thereforelikely that endogenous expression of Mls-1^a antigen shortlyafter birth activates V_ß6⁺CD4SP T cells and rendersthem anergic. This process of tolerance induction may precedethe clonal deletion of immature T cells in the thymus, describedin the adult mouse.